NCT03435172View on ClinicalTrials.gov

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

NASuspendedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2021

Conditions
Thermal Burn
Interventions
DEVICE

Device-ADRCs intravenously infusion

Medical Device: ADRCs Generated by Celution 800 IV Device and then Infused into Peripheral Vein.

Trial Locations (5)

20010

MedStar Health Research Institute, Washington D.C.

32610

University of Florida, Gainesville

43210

Ohio State University, Columbus

85008

Maricopa IHS, Phoenix

90033

Univeristy of Southern California, Los Angeles

Sponsors
All Listed Sponsors
lead

Cytori Therapeutics

INDUSTRY